8-K

Amcor plc (AMCR)

8-K 2021-02-02 For: 2021-02-02
View Original
Added on April 10, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K

CURRENT REPORT<br>Pursuant to Section 13 or 15(d)<br>of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 2, 2021

AMCOR PLC
(Exact name of registrant as specified in its charter)
Jersey 001-38932 98-1455367
--- --- ---
(State or other jurisdiction <br>of incorporation) (Commission File Number) (IRS Employer Identification No.)
83 Tower Road North
--- ---
Warmley, Bristol
United Kingdom BS30 8XP
(Address of principal executive offices) (Zip Code)

+44 117 9753200

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading symbol(s) Name of each exchange on which registered
Ordinary Shares, par value $0.01 per share AMCR The New York Stock Exchange
1.125% Guaranteed Senior Notes Due 2027 AUKF/27 The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On February 2, 2021, Amcor plc (the “Company”) issued a press release regarding financial results for the first half of fiscal year 2021. The press release is furnished as Exhibit 99.1 hereto. The Company is also furnishing an investor presentation relating to its first half of fiscal year 2021 (the “Presentation”), which will be used by management for presentations to investors and others. A copy of the Presentation is attached hereto as Exhibit 99.2 and incorporated into this Item 2.02 by reference. The Presentation is also available on the Company’s website at https://www.amcor.com/investors. The Company is not including the information contained on its website as part of, or incorporating it by reference into, this Current Report on Form 8-K.

The information in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 8.01 Other Events

On February 2, 2021, the Board of the Directors of the Company approved a $200 million repurchase of the Company’s ordinary shares and of the Company’s CDIs over the next twelve months. Pursuant to this program, purchases of the Company’s ordinary shares and CDIs will be made subject to market conditions and at prevailing market prices, through open market purchases. The Company expects to complete the share buyback over the next twelve months; however, the timing, volume and nature of repurchases may be amended, suspended or discontinued at any time.

Item 9.01. Financial Statements and Exhibits.

Exhibit Index

Exhibit No. Description
99.1 First Half of Fiscal Year 2021,Earnings Press Release
99.2 First Half Fiscal Year 2021, Earnings Investor Presentation
104 Cover Page Interactive Data File. The cover page XBRL tags are embedded within the inline XBRL document (contained in Exhibit 101)

Cautionary Statement Regarding Forward-Looking Statements

This Current Report on Form 8-K (including the Exhibits hereto) contains certain statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. The Company has identified some of these forward-looking statements with words like “believe,” “may,” “could,” “would,” “might,” “possible,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “estimate,” “potential,” “outlook” or “continue,” the negative of these words, other terms of similar meaning or the use of future dates. Such statements are based on the current expectations of the management of the Company, and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. None of the Company or any of its respective directors, executive officers or advisors, provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur. Risks and uncertainties that could cause results to differ from expectations include, but are not limited to, those discussed in the Company’s disclosures described under Part I, "Item 1A - Risk Factors" in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2020. Forward looking statements included herein are made only as of the date hereof and the Company does not undertake any obligation to update any forward-looking statements, or any other information in this Current Report on Form 8-K, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent. All forward-looking statements in this Current Report on Form 8-K are qualified in their entirety by this cautionary statement.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMCOR PLC
Date February 2, 2021 /s/ Damien Clayton
Name: Damien Clayton
Title: Company Secretary

Document

Exhibit 99.1

February 2, 2021, US; February 3 2021, Australia

Amcor reports first half results and raises outlook for fiscal 2021

Highlights - Six Months Ended December 31, 2020

•GAAP Net Income of $417 million, up 65%; GAAP earnings per share (EPS) of 26.5 cents per share, up 71%;

•Adjusted EPS of 33.3 cents per share, up 16% in constant currency terms;

•Adjusted EBIT of $743 million, up 8% in constant currency terms;

•$35 million Bemis cost synergies in H1; expect approximately $70 million (previously $50-$70 million) in FY21;

•A further $200 million of share repurchases approved bringing the total announced in fiscal 2021 to $350 million;

•Quarterly dividend higher than last year at 11.75 cents per share; and

•Fiscal 2021 outlook for adjusted EPS growth raised to 10-14% in constant currency terms (previously 7-12%).

Strong First Half and Increased Guidance and Shareholder Returns for Fiscal 2021
Amcor’s CEO Ron Delia said: “Amcor delivered strong financial results ahead of our expectations for the first half and we have raised the outlook for the full year as our teams continue to demonstrate resilience and outstanding execution."<br><br><br><br>"Sales growth of 3% was balanced across our businesses and regions, cost performance has been strong and synergies from the Bemis acquisition are running ahead of schedule. We have built momentum in both operating segments resulting in Adjusted EBIT growth of 9% in Flexibles and 10% in Rigid Packaging in constant currency terms. That momentum translates into higher expectations for the full year with Adjusted EPS growth now forecast at 10-14% in constant currency terms as well as an increased dividend and additional share repurchases.”<br><br><br><br>“Amcor’s investment case remains as strong as ever. We are well positioned to continue generating growth from attractive consumer and healthcare end markets, our leadership and scale in emerging markets and our extensive innovation capabilities. With annual free cash flow of more than $1 billion, we have substantial capacity to create value for shareholders by reinvesting in the business, pursuing acquisitions, and returning capital through a compelling and growing dividend and share repurchases.”

.

Key Financials(1)

GAAP results 2020 million
Net sales 6,200
Net income 417
EPS (diluted US cents) 26.5
Constant Currency ∆%
Half Year Ended December 31,
Adjusted non-GAAP results 2019 $ million 2020 million
Net sales(2) 6,184 6,200 3
EBITDA 911 948 5
EBIT 699 743 8
Net income 473 522 12
EPS (diluted US cents) 29.2 33.3 16
Free cash flow 310 276

All values are in US Dollars.

(1) Adjusted non-GAAP results exclude items which management considers as not representative of ongoing operations. Further details related to non-GAAP measures and reconciliations to GAAP measures can be found under "Presentation of non-GAAP financial information” and in the tables included in this release.

(2) Constant Currency ∆% for Net sales excludes 2% unfavorable impact from the pass through of lower raw material costs.

Note: All amounts referenced throughout this document are in US dollars unless otherwise indicated and numbers may not add up precisely to the totals provided due to rounding.

Bemis cost synergies

The Bemis business was acquired through an all-stock transaction in June 2019.

Amcor has continued to execute well against overhead, procurement and footprint initiatives and delivered approximately $35 million (pre-tax) of incremental cost synergies during the first half. Of this amount, approximately $30 million was recognized in the Flexibles segment and $5 million in Other.

As a result of this strong progress, Amcor expects to deliver incremental cost synergy benefits of approximately $70 million (pre-tax) in fiscal 2021 (previously $50 to $70 million (pre-tax)). Combined with the $80 million delivered in fiscal 2020, this will result in cumulative cost synergies of $150 million (pre-tax) by the end of fiscal 2021 and leaves the business well positioned to deliver total cost synergies of $180 million by the end of fiscal 2022.

Shareholder returns

Dividend

The Amcor Board of Directors today declared a quarterly cash dividend of 11.75 cents per share (compared with 11.5 cents per share in the same quarter last year). The dividend will be paid in US dollars to holders of Amcor’s ordinary shares trading on the NYSE. Holders of CDIs trading on the ASX will receive an unfranked dividend of 15.21 Australian cents per share, which reflects the quarterly dividend of 11.75 cents per share converted at an AUD:USD average exchange rate of 0.7724 over the five trading days ended January 28, 2021.

The ex-dividend date will be February 23, 2021, the record date will be February 24, 2021 and the payment date will be March 16, 2021.

Share repurchases

Amcor is committed to an investment grade credit rating, maintains strong credit metrics and generates significant annual free cash flow. This provides substantial capacity to simultaneously reinvest in the business, pursue acquisitions and return cash to shareholders through a compelling and growing dividend as well as share repurchases.

The Amcor Board of Directors has approved the repurchase of a further $200 million of ordinary shares and CDIs, bringing the total approved in fiscal 2021 to $350 million.

During the first half of fiscal 2021, Amcor repurchased 6.5 million shares, resulting in a 0.4% reduction in the total number of shares issued and outstanding.

Financial results - Half Year ended December 31, 2020

Segment information

Half Year Ended December 31, 2019 Half Year Ended December 31, 2020
Adjusted non-GAAP results(1) Net sales <br>$ million EBIT<br>$ million EBIT / Sales % EBIT / Average funds employed %(2) Net sales $ million EBIT<br>$ million EBIT / Sales % EBIT / Average funds employed %(2)
Flexibles 4,846 602 12.4 % 4,850 653 13.5 %
Rigid Packaging 1,340 127 9.5 % 1,352 134 9.9 %
Other (2) (30) (2) (45)
Total Amcor 6,184 699 11.3 % 13.8 % 6,200 743 12.0 % 14.6 %

(1) Adjusted non-GAAP measures exclude items which management considers as not representative of ongoing operations. Further details related to non-GAAP measures and reconciliations to GAAP measures can be found under "Presentation of non-GAAP financial information” and in the tables included in this release.

(2) Average funds employed includes shareholders equity and net debt, calculated using a four quarter average and LTM adjusted EBIT.

First half net sales for the Amcor Group of $6,200 million were 3% higher than the same period last year excluding a combined unfavorable impact of currency and the pass through of lower raw material costs. Overall volumes were 3% higher than the prior period and price/mix had no material impact on net sales.

Flexibles Constant Currency ∆%
Half Year Ended December 31,
2019 $ million 2020 million
Net sales(1) 4,846 4,850 % 1 %
Adjusted EBIT 602 653 8 % 9 %
Adjusted EBIT / Sales % 12.4 13.5

All values are in US Dollars.

(1) Constant Currency ∆% for Net sales excludes a 1% unfavorable impact from the pass through of lower raw material costs.

Overall first half segment volumes were 2% higher than the same period last year. All geographic regions delivered volume growth and by end market, growth in food, pet food and beverage was partially offset by lower volumes in certain healthcare end markets driven by reduced elective surgery rates and lower prescription trends.

Volume growth and a 1% unfavorable impact from price/mix resulted in overall sales being 1% higher than the prior period excluding a net unfavorable impact of currency and the pass through of lower raw material costs.

In North America, volumes grew in the mid single digit range, mainly driven by strength in the meat, frozen food, liquid beverage, pet food and home and personal care end markets as well as specialty folding cartons. This was partly offset by lower healthcare volumes. In Europe, growth strengthened through the half year and overall low single digit volume growth was driven by higher volumes in cheese, snacks, coffee, pet food and ready meal end markets partly offset by lower confectionary, yogurt and healthcare volumes.

Flexible packaging volumes grew at mid single digit rates across the Asian emerging markets, with mid single digit and double digit growth in China and India respectively, partly offset by lower volumes in South East Asia. In Latin America overall volumes grew in the low single digit range compared with the prior period.

Adjusted EBIT for the first half of $653 million was 9% higher than the prior period in constant currency terms. This includes organic growth of 4%, primarily reflecting higher volumes and strong cost and operating performance across the business. The remaining 5% earnings growth reflects $30 million of synergy benefits related to the Bemis acquisition.

Adjusted EBIT margin of 13.5% compares with 12.4% for the prior period.

Rigid Packaging Constant Currency ∆%
Half Year Ended December 31,
2019 $ million 2020 million
Net sales(1) 1,340 1,352 1 % 10 %
Adjusted EBIT 127 134 6 % 10 %
Adjusted EBIT / Sales % 9.5 9.9

All values are in US Dollars.

(1) Constant Currency ∆% for Net sales excludes a 7% unfavorable impact from the pass through of lower raw material costs.

Overall first half segment volumes were 6% higher than the same period last year, with volume growth in North America partially offset by marginally lower volumes in Latin America.

Price/mix had a 4% favorable impact and includes pricing to recover cost inflation in Latin America. Overall sales were therefore 10% higher than the prior period excluding the unfavorable impacts of currency and the pass through of lower raw material costs.

In North America, beverage volumes were 9% higher than the prior period with hot fill container volumes up 19%. There has been strong consumer demand across all beverage segments, particularly in hot fill juices as well as hot fill sports drinks where Amcor also benefited from favorable customer mix. Strong consumer demand reflects higher at home consumption of packaged beverages supported by higher retail sales in multi-pack formats across a range of segments. Growth was also driven by several launches of brand extensions and new health and wellness oriented products in PET containers. Specialty container volumes were also higher than the prior period with continuing growth in certain categories including spirits, personal care and home cleaning.

In Latin America, volumes were marginally lower than the prior period. Month to month volumes remain variable, however trends generally strengthened through the half year. Volumes were higher in Brazil, Central America and Argentina, offset by lower volumes across the rest of the region.

Adjusted EBIT for the first half of $134 million was 10% higher than the prior period in constant currency terms, reflecting positive mix across the business and higher volumes in North America partly offset by increased labor and transportation costs to service higher demand and lower volumes in Latin America.

Other Half Year Ended December 31,
Adjusted EBIT 2019 $ million 2020 $ million
AMVIG (equity accounted investment, net of tax) (1) 5 3
Corporate expenses (35) (48)
Total Other (30) (45)

(1) As announced on 24 September 2020, Amcor sold its investment in AMVIG. As a result no further earnings will be recognized in relation to this investment.

Net interest and income tax expense

First half net interest expense was $70 million compared with $99 million in the same period last year, with the decrease primarily driven by lower interest rates on floating rate debt. Offsetting this, first half tax expense (adjusted to exclude amounts related to non-GAAP adjustments) was $145 million compared with $123 million in the same period last year. Adjusted tax expense represents an effective tax rate of 21.5% in the current period.

Cash flow

First half adjusted free cash flow was $276 million. Excluding an unfavorable impact of approximately $50 million related to timing of cash tax payments in the US which were deferred from the fourth quarter of fiscal 2020, free cash flow was higher than the same period last year.

Balance sheet

Net debt was $5,730 million at 31 December 2020. Leverage, measured as net debt divided by adjusted trailing twelve month EBITDA, was 2.9 times, in line with Amcor's expectations.

Fiscal 2021 guidance

For the twelve month period ending 30 June 2021, the Company expects:

•Adjusted constant currency EPS growth of approximately 10 to 14% (previously 7 to 12%), compared with adjusted EPS of 64.2 US cents per share in fiscal 2020.

◦This includes pre-tax synergy benefits associated with the Bemis acquisition of approximately $70 million (previously $50 to $70 million).

◦Assuming current exchange rates prevail for the remainder of the year, it is estimated that currency would have no material impact on reported EPS.

•Adjusted free cash flow of approximately $1.0 to $1.1 billion.

Amcor’s guidance contemplates a range of factors, including the COVID-19 pandemic which creates a higher degree of uncertainty and additional complexity when estimating future financial results. Amcor's business has demonstrated resilience given that it plays an important role in the supply of essential consumer goods. While this is expected to continue, the level of earnings and free cash flow generated across the business could be impacted by COVID-19 related factors such as the extent and nature of any future operational disruptions across the supply chain, government imposed restrictions on consumer mobility and the pace of macroeconomic recovery in key global economies. The ultimate magnitude and duration of the pandemic’s future impact on the business remains uncertain at this time.

Conference Call

Amcor is hosting a conference call with investors and analysts to discuss these results on Tuesday February 2, 2021 at 5:30pm US Eastern Standard Time / Wednesday February 3, 9.30am Australian Eastern Daylight Time. Investors are invited to listen to a live webcast of the conference call at our website, www.amcor.com, in the “Investors” section.

Those wishing to access the call should use the following toll-free numbers, with the Conference ID 8641389:

•US & Canada – 866 211 4133

•Australia – 1800 287 011

•United Kingdom – 0800 051 7107

•Singapore – 800 852 6506

•Hong Kong – 800 901 563

From all other countries, the call can be accessed by dialing +1 647 689 6614 (toll).

A replay of the webcast will also be available in the Investors section on www.amcor.com following the call.

About Amcor

Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home and personal-care, and other products. Amcor works with leading companies around the world to protect their products and the people who rely on them, differentiate brands, and improve supply chains through a range of flexible and rigid packaging, specialty cartons, closures, and services. The company is focused on making packaging that uses less materials, is increasingly recyclable and reusable, and is made with more recycled content. Around 47,000 Amcor people generate $12.5 billion in annual sales from operations that span about 230 locations in 40-plus countries. NYSE: AMCR; ASX: AMC

www.amcor.com I LinkedIn I Facebook I Twitter I YouTube

Contact Information

Investors
Tracey Whitehead Damien Bird
Global Head of Investor Relations Vice President Investor Relations
Amcor Amcor
+61 3 9226 9028 +61 3 9226 9070
tracey.whitehead@amcor.com damien.bird@amcor.com
Media - Australia Media - Europe Media - North America
James Strong Ernesto Duran Daniel Yunger
Head of Global Communications
Citadel-MAGNUS Amcor Kekst CNC
+61 448 881 174 +41 78 698 69 40 +1 212 521 4879
jstrong@citadelmagnus.com ernesto.duran@amcor.com daniel.yunger@kekstcnc.com

Amcor plc UK Establishment Address: 83 Tower Road North, Warmley, Bristol, England, BS30 8XP, United Kingdom

UK Overseas Company Number: BR020803

Registered Office: 3rd Floor, 44 Esplanade, St Helier, JE4 9WG, Jersey

Jersey Registered Company Number: 126984, Australian Registered Body Number (ARBN): 630 385 278

Cautionary Statement Regarding Forward-Looking Statements

This document contains certain statements that are “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified with words like “believe,” “expect,”, “target,” “project,” “may,” “could,” “would,” “approximately,” “possible,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “estimate,” “potential,” “outlook,” or “continue,” the negative of these words, other terms of similar meaning or the use of future dates. Such statements are based on the current expectations of the management of Amcor and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. None of Amcor or any of its respective directors, executive officers or advisors provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur. Risks and uncertainties that could cause actual results to differ from expectations include, but are not limited to: the continued financial and operational impacts of the COVID-19 pandemic on Amcor and its customers, suppliers, employees and the geographic markets in which it and its customers operate; fluctuations in consumer demand patterns; the loss of key customers or a reduction in production requirements of key customers; significant competition in the industries and regions in which Amcor operates; failure to realize the anticipated benefits of the acquisition of Bemis Company, Inc. (“Bemis”), and the cost synergies related thereto; failure to successfully integrate Bemis’ business and operations in the expected time frame or at all; integration costs related to the acquisition of Bemis; failure by Amcor to expand its business; the potential loss of intellectual property rights; various risks that could affect our business operations and financial results due to our international operations; price fluctuations or shortages in the availability of raw materials, energy and other inputs; disruptions to production, supply and commercial risks, including counterparty credit risks, which may be exacerbated in times of economic downturn; the possibility of labor disputes; fluctuations in our credit ratings; disruptions to the financial or capital markets; and other risks and uncertainties identified from time to time in Amcor’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including without limitation, those described under Item 1A. “Risk Factors” of Amcor’s annual report on Form 10-K for the fiscal year ended June 30, 2020 and any subsequent quarterly reports on Form 10-Q. You can obtain copies of Amcor’s filings with the SEC for free at the SEC’s website (www.sec.gov). Forward-looking statements included herein are made only as of the date hereof and Amcor does not undertake any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent, except as expressly required by law. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.

Presentation of non-GAAP financial information

Included in this release are measures of financial performance that are not calculated in accordance with U.S. GAAP. These measures include adjusted EBIT (calculated as earnings before interest and tax), adjusted net income, adjusted earnings per share, adjusted free cash flow, and net debt. In arriving at these non-GAAP measures, we exclude items that either have a non-recurring impact on the income statement or which, in the judgment of our management, are items that, either as a result of their nature or size, could, were they not singled out, potentially cause investors to extrapolate future performance from an improper base. While not all inclusive, examples of these items include:

•material restructuring programs, including associated costs such as employee severance, pension and related benefits, impairment of property and equipment and other assets, accelerated depreciation, termination payments for contracts and leases, contractual obligations and any other qualifying costs related to the restructuring plan;

•earnings from discontinued operations and any associated profit or loss on sale of businesses or subsidiaries;

•consummated and identifiable divestitures agreed to with certain regulatory agencies as a condition of approval for Amcor’s acquisition of Bemis;

•impairments in goodwill and equity method investments;

•material acquisition compensation and transaction costs such as due diligence expenses, professional and legal fees and integration costs;

•material purchase accounting adjustments for inventory;

•amortization of acquired intangible assets from business combinations;

•payments or settlements related to legal claims; and

•impacts from hyperinflation accounting

Management has used and uses these measures internally for planning, forecasting and evaluating the performance of the company’s reporting segments and certain of the measures are used as a component of Amcor’s board of directors’ measurement of Amcor’s performance for incentive compensation purposes. Amcor also evaluates performance on a constant currency basis, which measures financial results assuming constant foreign currency exchange rates used for translation based on the rates in effect for the comparable prior-year period. In order to compute constant currency results, we multiply or divide, as appropriate, current-year U.S. dollar results by the current-year average foreign exchange rates and then multiply or divide, as appropriate, those amounts by the prior-year average foreign exchange rates. Constant currency net sales performance also excludes the impact from passing through movements in raw material costs. Amcor believes that these non-GAAP measures are useful to enable investors to perform comparisons of current and historical performance of the company. For each of these non-GAAP financial measures, a reconciliation to the most directly comparable U.S. GAAP financial measure has been provided herein. These non-GAAP financial measures should not be construed as an alternative to results determined in accordance with U.S. GAAP. The company provides guidance on a non-GAAP basis as we are unable to predict with reasonable certainty the ultimate outcome and timing of certain significant forward-looking items without unreasonable effort. These items include but are not limited to the impact of foreign exchange translation, restructuring program costs, asset impairments, possible gains and losses on the sale of assets and certain tax related events. These items are uncertain, depend on various factors and could have a material impact on U.S. GAAP earnings and cash flow measures for the guidance period.

Dividends

Amcor has received a waiver from the ASX’s settlement operating rules, which will allow the Company to defer processing conversions between its ordinary share and CDI registers from February 23, 2021 to February 24, 2021 inclusive.

U.S. GAAP Condensed Consolidated Statement of Income (Unaudited)

Three Months Ended December 31, Half Year Ended December 31,
($ million) 2019 2020 2019 2020
Net sales 3,043 3,103 6,184 6,200
Cost of sales (2,426) (2,452) (5,020) (4,895)
Gross profit 617 651 1,164 1,305
Selling, general and administrative expenses (309) (308) (680) (637)
Research and development expenses (23) (23) (49) (49)
Restructuring and related expenses (24) (23) (42) (46)
Other income, net 11 10 20 10
Operating income 272 307 413 583
Interest expense, net (46) (33) (99) (70)
Other non-operating income (loss), net 4 3 12 6
Income from continuing operations before income taxes and equity in income (loss) of affiliated companies 230 277 326 519
Income tax expense (45) (55) (67) (116)
Equity in income (loss) of affiliated companies, net of tax 3 5 19
Income from continuing operations 188 222 264 422
Income (loss) from discontinued operations, net of tax(1) (8)
Net income 188 222 256 422
Net (income) loss attributable to non-controlling interests (2) (3) (4) (5)
Net income attributable to Amcor plc 186 219 252 417
USD:EUR FX rate 0.8991 0.8558 0.9013 0.8473
Basic earnings per share attributable to Amcor 0.115 0.140 0.155 0.267
Diluted earnings per share attributable to Amcor 0.115 0.139 0.155 0.265
Weighted average number of shares outstanding – Basic 1,613 1,560 1,618 1,560
Weighted average number of shares outstanding - Diluted 1,615 1,570 1,620 1,568

(1) Represents income/(loss) generated from three former Bemis plants located in the United Kingdom and Ireland from July 1, 2019 to August 8, 2019. Amcor announced the disposal of these assets to Kohlberg & Company on June 25, 2019. This divestment was required by the European Commission at the time of approving Amcor’s acquisition of Bemis on February 11, 2019.

U.S. GAAP Condensed Consolidated Statement of Cash Flows (Unaudited)

Half Year Ended December 31,
($ million) 2019 2020
Net income 256 422
Depreciation, amortization and impairment 332 287
Changes in operating assets and liabilities (192) (253)
Other non-cash items (54) (14)
Net cash provided from operating activities 342 442
Purchase of property, plant and equipment and other intangible assets (207) (218)
Proceeds from sale of property, plant and equipment and other intangible assets 3 4
Proceeds from divestiture 397 138
Net debt (repayments) proceeds 178 40
Dividends paid (391) (374)
Share buy-back (223) (75)
Other, including effects of exchange rate on cash and cash equivalents (27) 55
Net increase in cash and cash equivalents 72 12
Cash and cash equivalents at the beginning of the period 602 743
Cash and cash equivalents at the end of the period 674 755

U.S. GAAP Condensed Consolidated Balance Sheet (Unaudited)

($ million) June 30, 2020 December 31, 2020
Cash and cash equivalents 743 755
Trade receivables, net 1,616 1,681
Inventories, net 1,832 1,843
Property, plant and equipment, net 3,615 3,767
Goodwill and other intangible assets, net 7,333 7,357
Other assets 1,303 1,315
Total assets 16,442 16,718
Trade payables 2,171 2,093
Short-term debt and current portion of long-term debt 206 53
Long-term debt, less current portion 6,028 6,432
Accruals and other liabilities 3,350 3,292
Shareholders equity 4,687 4,848
Total liabilities and shareholders equity 16,442 16,718

Reconciliation of Non-GAAP Measures

Reconciliation of adjusted Earnings before interest, tax, depreciation and amortization (EBITDA), Earnings before interest and tax (EBIT), Net income and Earnings per share (EPS)

Half Year Ended December 31, 2019 Half Year Ended December 31, 2020
($ million) EBITDA EBIT Net Income EPS (Diluted<br>US cents) EBITDA EBIT Net Income EPS (Diluted US cents)
Net income attributable to Amcor 252 252 252 15.5 417 417 417 26.5
Net income attributable to non-controlling interests 4 4 5 5
(Income) loss from discontinued operations 8 8 8 0.5
Tax expense 67 67 116 116
Interest expense, net 99 99 70 70
Depreciation and amortization 321 287
EBITDA, EBIT, Net income and EPS 751 430 260 16.0 895 608 417 26.5
Material restructuring and related costs 41 41 41 2.5 39 39 39 2.5
Net gain on disposals(1) (9) (9) (9) (0.6)
Material transaction and other costs(2) 101 101 101 6.3 13 13 13 0.8
Material impact of hyperinflation 18 18 18 1.1 11 11 11 0.7
Amortization of acquired intangibles(3) 109 109 6.8 82 82 5.2
Tax effect of above items (56) (3.5) (29) (1.8)
Adjusted EBITDA, EBIT, Net income and EPS 911 699 473 29.2 948 743 522 33.3

(1) Includes $15 million gain realised upon disposal of AMVIG and losses on disposal of other non-core businesses.

(2) Includes costs associated with the Bemis acquisition. The half year ended December 31, 2019 includes $58 million of acquisition related inventory fair value step-up costs.

(3) The half year ended December 31, 2019 includes $26 million of sales backlog amortization related to the Bemis acquisition.

Reconciliation of adjusted EBIT by reporting segment

Half Year Ended December 31, 2019 Half Year Ended December 31, 2020
($ million) Flexibles Rigid Packaging Other(1) Total Flexibles Rigid Packaging Other(1) Total
Net income attributable to Amcor 252 417
Net income attributable to non-controlling interests 4 5
(Income) loss from discontinued operations 8
Tax expense 67 116
Interest expense, net 99 70
EBIT 392 98 (60) 430 534 110 (36) 608
Material restructuring and related costs 32 6 3 41 27 10 2 39
Net gain on disposals(2) 6 (15) (9)
Material transaction and other costs(3) 72 2 27 101 7 1 5 13
Material impact of hyperinflation 18 18 11 11
Amortization of acquired intangibles(4) 106 3 109 79 3 82
Adjusted EBIT(5) 602 127 (30) 699 653 134 (45) 743
Adjusted EBIT / sales % 12.4 % 9.5 % 11.3 % 13.5 % 9.9 % 12.0 %

(1) Other includes equity in income (loss) of affiliated companies, net of tax and general corporate expenses.

(2) Includes $15 million gain realised upon disposal of AMVIG and losses on disposal of other non-core businesses.

(3) Includes costs associated with the Bemis acquisition. The half year ended December 31, 2019 includes $58 million of acquisition related inventory fair value step-up costs.

(4) The half year ended December 31, 2019 includes $26 million of sales backlog amortization related to the Bemis acquisition.

(5) During the first quarter of fiscal 2021, the Company reported that it revised the presentation of the reportable segments Adjusted EBIT to include an allocation of certain research and development and selling, general and administrative expenses that management previously reflected in Other. Prior periods have been recast to conform to the new cost allocation methodology.

Reconciliations of adjusted free cash flow

Half Year Ended December 31,
($ million) 2019 2020
Net cash provided from operating activities 342 442
Purchase of property, plant and equipment and other intangible assets (207) (218)
Proceeds from sale of property, plant and equipment and other intangible assets 3 4
Operating cash flow related to divested operations 60
Material transaction and integration related costs(1) 112 48
Adjusted free cash flow(2) 310 276

(1) The half year ended December 31, 2020 and 2019 includes cash restructuring and integration costs of approximately $31 million and $45 million respectively.

(2) Adjusted free cash flow excludes material transaction related costs because these cash flows are not considered to be directly related to the underlying business.

Half Year Ended December 31,
($ million) 2019 2020
Adjusted EBITDA 911 948
Interest paid, net (92) (65)
Income tax paid(2) (89) (168)
Purchase of property, plant and equipment and other intangible assets (207) (218)
Proceeds from sale of property, plant and equipment and other intangible assets 3 4
Movement in working capital (195) (209)
Other (21) (16)
Adjusted free cash flow(1) 310 276

(1) Adjusted free cash flow excludes material transaction related costs because these cash flows are not considered to be directly related to the underlying business.

(2) The half year ended December 31, 2019 excludes tax cash paid of $95 million related to disposal proceeds from divestments which were required by the European Commission and the U.S. Department of Justice at the time of approving Amcor’s acquisition of Bemis.

Reconciliation of net debt

($ million) June 30, 2020 December 31, 2020
Cash and cash equivalents (743) (755)
Short-term debt 195 40
Current portion of long-term debt 11 13
Long-term debt excluding current portion of long-term debt 6,028 6,432
Net debt 5,492 5,730

11

exhibit992

February 2, 2021 US February 3, 2021 Australia Ron Delia CEO Michael Casamento CFO 2021 Half Year Results NYSE: AMCR | ASX: AMC Exhibit 99.2


Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements This document contains certain statements that are “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified with words like “believe,” “expect,” “target,” “project,” “may,” “could,” “would,” “approximately,” “possible,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “estimate,” “potential,” “outlook” or “continue,” the negative of these words, other terms of similar meaning or the use of future dates. Such statements are based on the current expectations of the management of Amcor and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. None of Amcor or any of its respective directors, executive officers or advisors provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur. Risks and uncertainties that could cause actual results to differ from expectations include, but are not limited to: the continued financial and operational impacts of the COVID-19 pandemic on Amcor and its customers, suppliers, employees and the geographic markets in which it and its customers operate; fluctuations in consumer demand patterns; the loss of key customers or a reduction in production requirements of key customers; significant competition in the industries and regions in which Amcor operates; failure to real ize the anticipated benefits of the acquisition of Bemis Company, Inc. (“Bemis”), and the cost synergies related thereto; failure to successfully integrate Bemis’ business and operations in the expected time frame or at all; integration costs related to the acquisition of Bemis; failure by Amcor to expand its business; the potential loss of intellectual property rights; various risks that could affect our business operations and financial results due to our international operations; price fluctuations or shortages in the availability of raw materials, energy and other inputs; disruptions to production, supply and commercial risks, including counterparty credit risks, which may be exacerbated in times of economic downturn; the possibility of labor disputes; fluctuations in our credit ratings; disruptions to the financial or capital markets; and other risks and uncertainties identi fied from time to time in Amcor’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including without limitation, those described under Item 1A. “Risk Factors” of Amcor’s annual report on Form 10-K for the fiscal year ended June 30, 2020 and any subsequent quarterly reports on Form 10-Q. You can obtain copies of Amcor’s filings with the SEC for free at the SEC’s website (www.sec.gov). Forward-looking statements included herein are made only as of the date hereof and Amcor does not undertake any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent, except as expressly required by law. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement. Presentation of non-GAAP financial information Included in this release are measures of financial performance that are not calculated in accordance with U.S. GAAP. These measures include adjusted EBIT (calculated as earnings before interest and tax), adjusted net income, adjusted earnings per share, adjusted free cash flow, net debt and the Supplemental Unaudited Combined Financial Information including adjusted earnings before interest, tax, amortization and depreciation, adjusted earnings before interest and tax, and adjusted earnings per share and any ratios related thereto. In arriving at these non-GAAP measures, we exclude items that either have a non-recurring impact on the income statement or which, in the judgment of our management, are items that, either as a result of their nature or size, could, were they not singled out, potentially cause investors to extrapolate future performance from an improper base. While not all inclusive, examples of these items include: • material restructuring programs, including associated costs such as employee severance, pension and related benefits, impairment of property and equipment and other assets, accelerated depreciation, termination payments for contracts and leases, contractual obligations and any other qualifying costs related to the restructuring plan; • earnings from discontinued operations and any associated profit or loss on sale of businesses or subsidiaries; • consummated and identifiable divestitures agreed to with certain regulatory agencies as a condition of approval for Amcor’s acquisition of Bemis; • impairments in goodwill and equity method investments; • material acquisition compensation and transaction costs such as due diligence expenses, professional and legal fees and integration costs; • material purchase accounting adjustments for inventory; • amortization of acquired intangible assets from business combinations; • payments or settlements related to legal claims; and • impacts from hyperinflation accounting. Management has used and uses these measures internally for planning, forecasting and evaluating the performance of the company’s reporting segments and certain of the measures are used as a component of Amcor’s board of directors’ measurement of Amcor’s performance for incentive compensation purposes. Amcor also evaluates performance on a constant currency basis, which measures financial results assuming constant foreign currency exchange rates used for translation based on the rates in effect for the comparable prior-year period. In order to compute constant currency results, we multiply or divide, as appropriate, current-year U.S. dollar results by the current-year average foreign exchange rates and then multiply or divide, as appropriate, those amounts by the prior-year average foreign exchange rates. Constant currency net sales performance also excludes the impact from passing through movements in raw material costs. Amcor believes that these non-GAAP measures are useful to enable investors to perform comparisons of current and historical performance of the company. For each of these non-GAAP financial measures, a reconciliation to the most directly comparable U.S. GAAP financial measure has been provided herein. These non-GAAP financial measures should not be construed as an alternative to results determined in accordance with U.S. GAAP. The company provides guidance on a non-GAAP basis as we are unable to predict with reasonable certainty the ultimate outcome and timing of certain significant forward-looking items without unreasonable effort. These items include but are not limited to the impact of foreign exchange translation, restructuring program costs, asset impairments, possible gains and losses on the sale of assets and certain tax related events. These items are uncertain, depend on various factors and could have a material impact on U.S. GAAP earnings and cash flow measures for the guidance period.


4.1 4.0 3.4 2.6 2.0 2.0 2.0 2.4 2.6 2.1 3.2 2.8 2.4 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 Safety 3 Recordable-case frequency rate (per million hours worked) Acquisition impacts Notes: Recordable cases per million hours worked. All data shown for a 12 month period ended June 30, unless otherwise indicated. 2010 to 2012 includes the demerged Orora business. 2015 to 2018 include acquired businesses from the first day of ownership. The Bemis acquisition is excluded for all periods labelled 2010 through 2019. 2019PF and onwards includes Bemis. The increase in frequency rate between 2016 and 2018 reflects inclusion of the Alusa and Sonoco acquisitions and the increase between 2019 and 2019PF reflects the inclusion of the Bemis acquisition. • Staying safe and healthy – our first priority for 2021 fiscal year • 29% reduction in number of injuries compared with 1H20 • 54% of sites injury free for >12 months • All business groups reporting fewer injuries than 1H20 Committed to our goal of ‘no injuries’


Key messages for today 4 1. Strong first half result ahead of expectations 2. Raised guidance for fiscal 2021 EPS growth to 10-14% 3. Increased dividend and additional share repurchases 4. The Amcor investment case has never been stronger Strong first half, increased guidance and shareholder returns Note: Refer slide 16 for further information regarding revised guidance for fiscal 2021 EPS growth


Global leader in consumer packaging 5 • Founded in Australia in 1860 • NYSE (AMCR) and ASX (AMC) listed • ~$17 bn market cap • FY20 sales of $12.5 bn & Adjusted EBITDA of $1.9 bn • ~230 locations, ~47,000 employees, >40 countries Notes: Market cap data as of January 29, 2021 HPC is Home & Personal Care North America 47% Western Europe 24% Emerging markets 26% ANZ 3% $12.5 bn FY20 sales by geography Global reach, geographically balanced >$3 bn Emerging Markets sales Food 44% Bev erage 24% Healthcare 14% HPC 5% Other consumer 9% Other 4% $12.5 bn FY20 sales by end market Differentiated consumer packaging ~$2 bn Healthcare sales


Adjusted EBITDA CAGR +6% Notes: 10 year CAGR based on 2010 IFRS results as reported by Amcor in AUD converted at an FX rate of 0.876 compared to 2020 US GAAP results. Compound TSR reflects period from 1 July 2010 to 30 June 2020 based on local currency Investment grade credit rating >20 YEARS Adjusted EPS CAGR +8% TSR CAGR +15% Average Dividend Yield (6% DPS CAGR) 4.6% Fiscal 2010 - 2020 Proven track record of financial performance 6


Amcor Shareholder Value Creation Model 7 Substantial cash flow funds multiple drivers of value for shareholders 7 SIGNIFICANT ANNUAL CASH FLOW Capital expenditure (~ $500 m) Acquisitions / share repurchases (~ $300-400 m) EPS growth ~ 5-10% (Organic ~ 3-4%) Total Shareholder Value (EPS growth + yield) 10-15% per year Dividend (~ $750 m) Historical yield ~ 4-5%


The Amcor investment case has never been stronger Global industry leader with proven track record and clear strategy Consistent growth from consumer and healthcare end markets Attractive and growing dividend with current yield >4% Strong balance sheet, substantial capacity to invest and many growth opportunities Momentum building - organic growth plus synergies EPS growth + Dividend yield = 10-15% per year 8 Slide as presented in Amcor’s September 2020 Investor Briefing


Multiple drivers of organic growth Markets Growing consumer markets 1 Proactive Mix Management End segments, Products, Customers Innovation Differentiated products Cost Productivity Scale and capabilities 2 3 4 Sustainability Amcor’s greatest opportunity for growth and differentiation Industry first microwaveable recycle ready pouch Bio-based coffee packaging Leadership positions in growing end markets healthcare, food and beverage Balanced global reach with >$3 bn sales in Emerging Markets Lightest weight edible oil PET container in Brazil Protein, premium coffee, hot fill containers, barrier films, etc. 9 Reusable structure +7%*+20%* Growth and margin from higher value market & product segments * Amcor 1H21 volume growth ~$2 bn healthcare sales across pharmaceutical and medical device segments Delivering innovative, more sustainable packaging


10 Comprehensive sustainability agenda Independent recognition for our ESG strategy and progress 10 Responsible Packaging: Packaging Design Waste Management Infrastructure Compostable Recycle ready Paper Aluminum100% recycled material Consumer Participation Full range of sustainable packaging options Leadership roles in partnerships across the value chain Bio based materials Waste Management


Outstanding execution Safety, working capital, Bemis synergies, cost performance, innovation Fiscal 2021 first half result summary 11 Strong result ahead of expectations EPS 33.3 cents EBIT $743 million EBIT margin 12.0% +16% +8% +70bps Strong cash flow & increasing shareholder returns Quarterly dividend higher than last year at 11.75 US cps A further $200 million of share repurchases, bringing total announced in fiscal 2021 to $350 million Notes: EPS, EBIT and EBIT margins presented on an adjusted basis. Adjusted non-GAAP measures exclude items which management considers as not representative of ongoing operations. Further details related to non-GAAP measures and reconciliations to U.S. GAAP measures can be found in the appendix section. EPS and EBIT growth rates expressed in constant currency terms.


Highlights • Adjusted EBIT growth 9% on a constant currency basis • 4% organic growth • 5% ($30 million) synergy benefits • Higher volumes • Low to mid single digit growth in all regions • Volume growth in meat, snack food, cheese and frozen food, pet food and beverage • Strong cost performance • Innovative product launches for new and existing customers in food, personal care, medical and beverage end markets. First half result - Flexibles segment 12 Notes: Non-GAAP measures exclude items which management considers are not representative of ongoing operations. Further details related to non-GAAP measures and reconciliations to U.S. GAAP measures can be found in the appendix section. . 9% Adjusted EBIT growth compared with last year 1H20 1H21 Adjusted EBIT ($m) 602 653 +9% Adjusted EBIT margin 12.4% 13.5% Recycle ready product launch for a leading dairy brand in China First designed to be recycled PVDC free shrink bag for protein


80 ~150 Delivered fiscal 2020 Expected fiscal 2021 Cumulative expected by end fiscal 2021 Cumulative expected by end fiscal 2022 Annual cost synergies delivered and expected ($ million) 13 Bemis cost synergies tracking ahead of expectations $35 million benefit in first half fiscal 2021 ~$70 million expected in fiscal 2021 (previously $50 to $70 million). Well positioned to deliver total of $180 million 13 ~70 ~35 180


First half result - Rigid Packaging segment 14 Notes: Non-GAAP measures exclude items which management considers are not representative of ongoing operations. Further details related to non-GAAP measures and reconciliations to U.S. GAAP measures can be found in the appendix section. PCR refers to Post Consumer Recycled. 86% PCR applies to 118ml containers. 10% Adjusted EBIT growth compared with last year Highlights • Adjusted organic EBIT growth of 10% on a constant currency basis • Higher volumes and positive mix • North America volumes up • Beverage volumes up 9% - hot fill up 19% • Specialty Container volumes higher • Latin America volumes marginally lower • New innovations to support customer product launches, increase use of post consumer recycled material and lighter weight containers Increased use of recycled material conversion to 86% PCR container New product launch in PET format for a leading US brand 1H20 1H21 Adjusted EBIT ($m) 127 134 +10% Adjusted EBIT margin 9.5% 9.9%


First half results – strong cash flow & shareholder returns 15 (1) Non-GAAP measures exclude items which management considers as not representative of ongoing operations. Further details related to non-GAAP measures and reconciliations to U.S. GAAP measures can be found in the appendix section. (2) Adjusted free cash flow excludes material transaction related costs because these cash flows are not considered to be directly related to the underlying business. (3) Leverage calculated as net debt divided by adjusted trailing twelve month EBITDA. Strong cash flow, substantial capacity to invest and increasing shareholder returns Adjusted free cash flow in line with expectations and on track to deliver >$1 bn in fiscal 2021 10.7% 9.5% 8.2% Jun 19 Jun-20 Dec-20 Average w orking capital to sales (%) Year to date cash flow ($ million) 1H20 1H21 Adjusted EBITDA 911 948 Interest and tax payments (181) (233) Capital expenditure (207) (218) Movement in working capital (195) (209) Other (18) (12) Adjusted free cash flow(1)(2) 310 276 Balance sheet December 2020 EBITDA interest cover (x) 12.5 Leverage: Net debt / LTM EBITDA (x) 2.9 Strong investment grade balance sheet and leverage in line with expectations Increasing cash returns to shareholders Dividend higher than last year $350m share repurchases announced in FY21


16 Note: Reconciliations of the FY21 projected non-GAAP measures are not included herein because the individual components are not known with certainty as individual financial statements for fiscal 2021 have not been completed. Raised EPS guidance for 2021 fiscal year Amcor’s guidance contemplates a range of factors, including the COVID-19 pandemic which creates a higher degree of uncertainty and additional complexity when estimating future financial results. Amcor's business has demonstrated resilience given that it plays an important role in the supply of essential consumer goods. While this is expected to continue, the level of earnings and free cash flow generated across the business could be impacted by COVID-19 related factors such as the extent and nature of any future operational disruptions across the supply chain, government imposed restrictions on consumer mobility and the pace of macroeconomic recovery in key global economies. The ultimate magnitude and duration of the pandemic’s future impact on the business remains uncertain at this time. Adjusted constant currency EPS growth of approximately 10 to 14% (previously 7 to 12%) compared to 64.2 cents in fiscal 2020 Assuming current exchange rates prevail for the remainder of the year, it is estimated that currency would have no material impact on reported EPS. Adjusted free cash flow of approximately $1.0 to $1.1 billion For fiscal 2021 the Company expects:


Summary 17 1. Strong first half result ahead of expectations 2. Raised guidance for fiscal 2021 EPS growth to 10-14% 3. Increased dividend and additional share repurchases 4. The Amcor investment case has never been stronger Strong first half, increased guidance and shareholder returns Note: Refer slide 16 for further information regarding revised guidance for fiscal 2021 EPS growth


Appendix slides 2021 First half results – supplementary schedules and reconciliations


FX translation impact 19 EUR, 20-30% Other currencies(3), 20-30% USD(2), 45-55% EUR:USD Euro strengthened vs USD, Average USD to EUR rate 1H21 0.8473 vs 1H20 0.9013 USD million impact on 1H21 adjusted net income 6% 7 Other currencies(3):USD Other currencies weighted average vs USD weakened for 1H21 vs 1H20 average rates USD million impact on 1H21 adjusted net income (12%) (14) (1) Approximate range based on estimated combined adjusted net income by currency. (2) Includes all businesses effectively managed as USD functional currency businesses. (3) Includes all currencies other than USD and EUR. Total currency impact $ million Adjusted EBIT (9) Adjusted net income (7) Combined net income currency exposures(1) 1H21 currency impact


Historical Growth 20 Sales $m CC Growth2 Volume Price/ Mix 1H20 6,184 -2% -1% -1% 2H20 6,284 1% 1% 0% FY20 12,468 0% 0% 0% 1H21 6,200 3% 3% 0% EBIT $m CC Growth2 Synergies % Organic % 1H20 699 4% 4% 0% 2H20 798 9% 7% 2% FY20 1,497 7% 6% 1% 1H21 743 8% 5% 3% EPS cps CC Growth2 1H20 29.2 11% 2H20 35.0 15% FY20 64.2 13% 1H21 33.3 16%A M C O R G R O U P SALES Adjusted EBIT Adjusted EPS Sales $m CC Growth2 Volume Price/ Mix 1H20 4,846 -1% -1% -1% 2H20 4,909 1% 1% 0% FY20 9,755 0% 0% 0% 1H21 4,850 1% 2% -1% EBIT $m CC Growth2 Synergies % Organic % 1H20 602 5% 3% 2% 2H20 694 8% 6% 3% FY20 1,296 7% 5% 2% 1H21 653 9% 5% 4% F L E X IB L E S Sales $m CC Growth2 Volume Price/ Mix 1H20 1,340 -2% -0% -1% 2H20 1,377 0% 1% -1% FY20 2,716 -1% 0% -1% 1H21 1,352 10% 6% 4% EBIT $m CC Growth2 Synergies % Organic % 1H20 127 -14% - -14% 2H20 156 1% - 1% FY20 284 -6% - -6% 1H21 134 10% - 10% R IG ID S (1) Non-GAAP measures exclude items which management considers as not representative of ongoing operations. Further details related to non-GAAP measures and reconciliations to U.S. GAAP measures can be found in the appendix section (2) CC Growth reflects: Sales- constant currency growth excluding the pass through of raw material costs.


Reconciliations of non-GAAP financial measures 21


Reconciliations of non-GAAP financial measures 22


Reconciliations of non-GAAP financial measures 23 Reconciliation of adjusted EBIT by reporting segment ($ million) Flexibles Rigid Packaging Other (1) Total Net income attributable to Amcor 612 Net income attributable to non-controll ing interests 4 (Income) / loss from discontinued operations 8 Tax expense 187 Interest expense, net 185 EBIT 971 210 (185) 996 Material restructuring and related costs 63 38 5 106 Impairment in equity method investments - - 26 26 Material transaction and other costs (2) 77 3 66 146 Material impact of hyperinflation - 28 - 28 Pension settlement - - 5 5 Amortisation of acquired intangibles (3) 185 5 - 190 Adjusted EBIT 1,296 284 (83) 1,497 Adjusted EBIT / sales % 13.3% 10.4% 12.0% (1) Other includes equity in income (loss) of affiliated companies, net of tax and general corporate expenses. (2) Includes costs associated with the Bemis acquisition. The twelve months ended June 30, 2020 includes $58 million of acquisition related inventory fair value step-up costs. (3) The twelve months ended June 30, 2020 includes $26 million of sales backlog amortization related to the Bemis acquisition. Twelv e months ended June 30, 2020


Reconciliations of non-GAAP financial measures 24